Patrick K. Donnelly, Managing Partner

Former Chairman and CEO of Aptiv Solutions (global clinical development services company); Founder, President and CEO of PRA International (leading global CRO) - led the company through its IPO in 2004; President of Virginia Capital, L.P.

Daniel Behr, MBA, Co-Founder and Partner

Serial entrepreneur, venture investor and technology transfer professional – focused on commercialization of biotech and medtech technologies. Most recently at Access BridgeGap Ventures (asset-focused biotech investments)

Dennis Underwood, Ph.D., Co-Founder, CSO and Partner

Over 25 years executive experience in pharma, biotech and startups. Well schooled in the art and science of drug discovery and development – with 3 drugs approved and in the market. Recognized leader in systems pharmacology

Ed Kahn, Co-Founder and Partner

Intellectual property expert; and the founding president of EKMS, Inc., a company known for pioneering novel IP management techniques for two decades; Director of Strategic Business Development at Cures Within Reach

Safia Rizvi, Ph.D., MBA, Advisor

Senior life science executive with over 15 years of experience in global life sciences and biopharma (UCB, Medimmune, GSK); currently VP and General Manager of U.S. Pharmaceutical Business for Galderma

Dr. Bruce Bloom, Ashoka Fellow, Advisor

Founder, President and Chief Science Officer of Cures Within Reach, successfully repurposing drugs and other treatments to speed cures to patients

William Koster, Ph.D., Advisor

Former Senior VP and global head of drug discovery and development at Bristol Myers Squibb; former CEO of Neurogen; currently Director of several biotech companies

Robert Bratzler, Ph.D., Advisor

Bob Bratzler is a pioneering and experience biopharma entrepreneur. Among other things, he co-founded both Sepracor and Selecta, and was CEO of Coley Pharma.

Lita Nelsen, Advisor

Lita Nelsen recently retired from her position as Director of the Technology Licensing Office at the Massachusetts Institute of Technology, where she had been since 1986. She now works as a consultant in technology transfer and entrepreneurship in the US, Europe and Asia.